Riskpilot← Back to searchSign inGet full accessFANGEL BIOENERGI ApS
APSActiveCVR 26262119Dronning Sophies Allé 7AManufacture of gas · NACE 3521Est. 20019 employees
Revenue 2024
DKK 14,7M
+260% vs 2023
EBITDA margin
65.3%
+1566% vs 2023
Equity ratio
48.2%
Financial strength
Net profit 2024
DKK 785K
+109% vs 2023
| Revenue | DKK 14,7M | +260% |
| EBITDA | DKK 9,6M | +1566% |
| Net profit | DKK 785K | +109% |
| Total assets | DKK 112,6M | +2% |
| Equity | DKK 54,3M | +1% |
| Employees | 9 | — |
Legal name
FANGEL BIOENERGI ApS
CVR number
26262119
Legal form
Anpartsselskab
NACE code
3521 · Manufacture of gas
Founded
1. oktober 2001
Share capital
DKK 125.000
Employees
9 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør.
Company purpose
Selskabets formål er at udøve virksomhed med investering, handel og finansiering samt aktiviteter i tilknytning hertil.
Address
Dronning Sophies Allé 7A
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 32.103 | 40.600 | -4.108 | 4.088 | 14.700 |
| Staff expenses | -3.749 | -5.706 | -4.195 | -4.743 | -5.104 |
| EBITDA | 28.354 | 34.894 | -8.304 | -655 | 9.595 |
| Depreciation & amort. | -15.630 | -18.149 | -8.699 | -8.001 | -7.157 |
| EBIT | 12.724 | 16.745 | -17.002 | -8.655 | 2.438 |
| Net financials | -97 | -1.428 | -362 | -1.036 | -1.352 |
| Profit before tax | 12.627 | 15.316 | -17.364 | -9.692 | 1.087 |
| Tax | 2.807 | 3.491 | -3.820 | -1.078 | 302 |
| Net profit | 9.820 | 11.825 | -13.544 | -8.613 | 785 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 165.782 | 139.454 | 135.539 | 110.703 | 112.556 |
| Equity | 63.834 | 75.659 | 62.115 | 53.502 | 54.287 |
| Long-term debt | 31.199 | 27.512 | 23.814 | 19.929 | 16.227 |
| Short-term debt | 59.673 | 27.257 | 40.319 | 26.739 | 31.277 |
| Total debt | 90.872 | 54.770 | 64.133 | 46.668 | 47.505 |
EBITDA margin
65.3%
This company
15.8%
Market median
+313% vs market
20202024
Equity ratio
48.2%
This company
38.2%
Market median
+26% vs market
20202024
Return on equity
1.4%
This company
18.4%
Market median
-92% vs market
20202024
Net profit margin
5.3%
This company
8.1%
Market median
-35% vs market
20202024
Asset turnover
0.13×
This company
1.12×
Market median
-88% vs market
20202024
Debt / equity
1.07×
This company
0.62×
Market median
-73% vs market
20202024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
TR Management | Management | 2023 |
HV Chief Executive Officer | Chief Executive Officer | 2020 |
| Former (1) | ||
KB Management | Management | 2001 – 2023 |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2011 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
KB Holding 2018 ApS
FANGEL BIOENERGI ApS Board members of FANGEL BIOENERGI ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Karsten Buchhave | Management | 0 companies |
| Torben Ravn Pedersen | Management | 0 companies |
| Henrik Vestergaard Laursen | Chief Executive Officer | 0 companies |